Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer

by Corona, Silvia Paola, Generali, Daniele
Published in Drug Des Devel Ther (2018)

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer

by Roviello, Giandomenico, Corona, Silvia Paola, Bonetta, Alberto, Cappelletti, Maria Rosa, Generali, Daniele
Published in Onco Targets Ther (2017)

Isolated Testicular Metastasis from Prostate Cancer

by Bonetta, Alberto, Generali, Daniele, Corona, Silvia Paola, Cancarini, Gianni, Brenna, Sarah Grazia, Pacifico, Chiara, Roviello, Giandomenico
Published in Am J Case Rep (2017)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

by Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
Published in Cells (2019)

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer

by Roviello, Giandomenico, Corona, Silvia Paola, Multari, Andrea Giovanni, Paganini, Giovanni, Chiriacò, Giorgio, Conca, Raffaele, Petrioli, Roberto, Generali, Daniele, Rosellini, Pietro, Aieta, Michele
Published in Oncotarget (2018)

Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature

by Bernocchi, Ottavia, Sirico, Marianna, Corona, Silvia Paola, Strina, Carla, Milani, Manuela, Cappelletti, Maria Rosa, Ferrero, Giuseppina, Ziglioli, Nicoletta, Cervoni, Valeria, Macchiavelli, Andrea, Roviello, Giandomenico, Generali, Daniele
Published in Pharmaceuticals (Basel) (2021)

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer

by Milani, Manuela, Venturini, Sergio, Bonardi, Simone, Allevi, Giovanni, Strina, Carla, Cappelletti, Maria Rosa, Corona, Silvia Paola, Aguggini, Sergio, Bottini, Alberto, Berruti, Alfredo, Jubb, Adrian, Campo, Leticia, Harris, Adrian L., Gatter, Kevin, Fox, Stephen B., Generali, Daniele, Roviello, Giandomenico
Published in Oncotarget (2017)

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

by Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele
Published in Breast Cancer Res Treat (2020)

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

by Schettini, Francesco, Corona, Silvia Paola, Giudici, Fabiola, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Ziglioli, Nicoletta, Aguggini, Sergio, Azzini, Carlo, Barbieri, Giuseppina, Cervoni, Valeria, Cappelletti, Maria Rosa, Molteni, Alfredo, Lazzari, Maria Chiara, Ferrero, Giuseppina, Ungari, Marco, Marasco, Elena, Bruson, Alice, Xumerle, Luciano, Zago, Elisa, Cerra, Davide, Loddo, Marco, Williams, Gareth H., Paris, Ida, Scambia, Giovanni, Generali, Daniele
Published in Front Oncol (2021)